发明授权
- 专利标题： Imidazotriazines as protein kinase inhibitors
- 专利标题（中）： 咪唑三嗪作为蛋白激酶抑制剂
-
申请号： US11185599申请日： 2005-07-20
-
公开(公告)号： US07741324B2公开(公告)日： 2010-06-22
- 发明人: Andrew Philip Crew , Mark Joseph Mulvihill , Douglas Scott Werner
- 申请人： Andrew Philip Crew , Mark Joseph Mulvihill , Douglas Scott Werner
- 申请人地址： US NY Melville
- 专利权人： OSI Pharmaceuticals, Inc.
- 当前专利权人： OSI Pharmaceuticals, Inc.
- 当前专利权人地址： US NY Melville
- 主分类号： C07D487/04
- IPC分类号： C07D487/04 ; C07D487/12 ; A61K31/53 ; A61K35/00
摘要：
Compounds of the formula and pharmaceuticaly acceptable salts thereof, wherein Q1 and R1 are defined herein, inhibit the IGF-1R enzyme and are useful for the treatment and/or prevention of various diseases and conditions that respond to treatment by inhibition of tyrosine kinases.
公开/授权文献
- US20060019957A1 Imidazotriazines as protein kinase inhibitors 公开/授权日：2006-01-26
信息查询
